AUTOLOGOUS VERSUS HAPLOIDENTICAL DONOR STEM CELL TRANSPLANTATION FOR FAVORABLE-AND INTERMEDIATERISK ACUTE MYELOID LEUKEMIA IN FIRST REMISSION AND UNDETECTABLE MINIMAL RESIDUAL DISEASE: A MULTI-CENTER, PROSPECTIVE STUDY

被引：0
|
作者：
Ding, Yiyang [1 ]
Ru, Yuhua [1 ]
Zhu, Jinjin [1 ]
Zhang, Xi [2 ]
Liu, Lin [3 ]
Jiang, Erlie [4 ]
Huang, He [5 ]
Wang, Jishi [6 ]
Hu, Jiong [7 ]
Zhang, Yanming [8 ,9 ]
Xu, Yajing [10 ]
Yang, Mingzhen [11 ]
Chen, Jia [1 ]
Wu, Depei [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Suzhou, Peoples R China
[2] Third Mil Med Univ, Xinqiao Hosp, Chongqing, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
[5] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Peoples R China
[6] Guizhou Med Univ, Affiliated Hosp, Guiyang, Peoples R China
[7] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Natl Res Ctr Translat Med Shanghai, Ruijin Hosp,Sch Med,Shanghai Inst Hematol, Shanghai, Peoples R China
[8] Xuzhou Med Coll, Huaian Hosp, Huaian, Peoples R China
[9] Huaian Second Peoples Hosp, Huaian, Peoples R China
[10] Cent South Univ, XiangYa Hosp, Changsha, Peoples R China
[11] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P001
引用
收藏
页码：140 / 141
页数：2
相关论文
共 50 条
  • [31] Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes
    Brammer, J. E.
    Saliba, R. M.
    Jorgensen, J. L.
    Ledesma, C.
    Gaballa, S.
    Poon, M.
    Maziarz, R. T.
    Champlin, R. E.
    Hosing, C.
    Kebriaei, P.
    BONE MARROW TRANSPLANTATION, 2017, 52 (01) : 20 - 27
  • [32] Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes
    J E Brammer
    R M Saliba
    J L Jorgensen
    C Ledesma
    S Gaballa
    M Poon
    R T Maziarz
    R E Champlin
    C Hosing
    P Kebriaei
    Bone Marrow Transplantation, 2017, 52 : 20 - 27
  • [33] LONG TERM OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS: THE ROLE OF MINIMAL RESIDUAL DISEASE
    Paolini, S.
    Romani, L.
    Ottaviani, E.
    Marconi, G.
    Papayannidis, C.
    Parisi, S.
    Sartor, C.
    Nanni, J.
    Cristiano, G.
    Abbenante, M. C.
    Talami, A.
    Olivi, M.
    Ragaini, S.
    Bandini, L.
    Venturi, C.
    Raffini, M.
    Robustelli, V.
    Martinelli, G.
    Testoni, N.
    Baldazzi, C.
    Cavo, M.
    Curti, A.
    HAEMATOLOGICA, 2019, 104 : 46 - 46
  • [34] GRAFT VERSUS LEUKEMIA EFFECT OF ALLOGENEIC STEM CELL TRANSPLANTATION AND MINIMAL RESIDUAL DISEASE IN PATIENTS WITH AML IN FIRST COMPLETE REMISSION
    Versluis, J.
    Kalin, B.
    Zeijlemaker, W.
    Passweg, J.
    Graux, C.
    Manz, M.
    Vekemans, M-C
    Biemond, B.
    Legdeur, M-C
    Kooy, M. van Marwijk
    Janssen, J.
    Pabst, T.
    Lowenberg, B.
    Jongen-Lavrencic, M.
    Schuurhuis, G. J.
    Ossenkoppele, G.
    Cornelissen, J.
    HAEMATOLOGICA, 2017, 102 : 7 - 7
  • [35] Comparison of outcomes for patients with acute myeloid leukemia undergoing haploidentical stem cell transplantation in first and second complete remission
    Wen-Jing Yu
    Yu-qian Sun
    Lan-Ping Xu
    Xiao-Hui Zhang
    Kai-Yan Liu
    Xiao-Jun Huang
    Yu Wang
    Annals of Hematology, 2023, 102 : 2241 - 2250
  • [36] Comparison of outcomes for patients with acute myeloid leukemia undergoing haploidentical stem cell transplantation in first and second complete remission
    Yu, Wen-Jing
    Sun, Yu-qian
    Xu, Lan-Ping
    Zhang, Xiao-Hui
    Liu, Kai-Yan
    Huang, Xiao-Jun
    Wang, Yu
    ANNALS OF HEMATOLOGY, 2023, 102 (08) : 2241 - 2250
  • [37] AUTOLOGOUS HEMATOPOEITIC STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN FIRST OR SECOND REMISSION
    Naqvi, H.
    John, V
    Devoe, C.
    Kiner, B.
    Kolitz, J.
    Allen, S.
    Gissinger, D.
    Cannon, M.
    Fitzgerald, E.
    Klocke, J.
    Bayer, R-L
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 39 - 39
  • [38] Autologous peripheral blood stem cell transplantation in children diagnosed with acute myeloid leukemia in first complete remission
    Fernandez-Plaza, S
    Lassaletta, A
    Pacheco, M
    Cañellas, M
    Sevilla, J
    Gonzalez-Vincent, M
    Diaz, MA
    Madero, L
    BONE MARROW TRANSPLANTATION, 2005, 35 : S107 - S107
  • [39] IMPACT OF PRE-TRANSPLANTATION MINIMAL RESIDUAL DISEASE OF MYELOABLATIVEHEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA
    Zhu, Mingqing
    Dai, Lan
    Chen, Li
    Shen, Wenhong
    Tang, Xiaowen
    Ruan, Changgeng
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 : 61 - 61
  • [40] Allogeneic stem cell transplantation is the optimal post-remission therapy in minimal residual disease positive patients with acute myeloid leukemia
    Gianni, L.
    Buccisano, F.
    Maurillo, L.
    Del Poeta, G.
    Del Principe, I
    Ottaviani, I
    Sarlo, C.
    Ammatuna, E.
    Campagna, S.
    Imo Consalvo, M.
    Amadori, A.
    Venditti, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 69 - 69
12345